Latest Breaking News On - Health media relations zeno group - Page 1 : comparemela.com

Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr

Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesTed jenkinsviceKamal hamedLora grassilliAdministration for strategic preparednessHuman servicesSpero therapeutics incDrug administrationMeiji seika pharma coBiomedical advanced researchExchange commissionHealth media relations zeno groupDevelopment authorityDepartment of healthSpecial protocol assessment

Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3

Phase3PIVOT-POtrialisexpectedtobeginwithFirstPatient,FirstVisitin4Q2023

United statesUnited kingdomTed jenkinsKamal hamedLora grassilliDrug administrationTebipenem hbr researchExchange commissionHealth media relations zeno groupHuman servicesMeiji seika pharma coAdministration for strategic preparednessDevelopment authorityBiomedical advanced researchDepartment of healthSpero therapeutics inc